Evidence map›Paper›PMID 31242703›Full record

ArticleMolecules (Basel, Switzerland)2019

Essential Oil of

Chih-Ting Chang, Wen-Ni Soo, Yu-Hsin Chen, Lie-Fen Shyur

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. The Wonderful Activities of the GenusMolecules (Basel, Switzerland) · 2021
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Chih-Ting ChangAgricultural Biotechnology Research Center, Academia Sinica, Taipei 115, Taiwan.
Wen-Ni SooAgricultural Biotechnology Research Center, Academia Sinica, Taipei 115, Taiwan.
Yu-Hsin ChenTaichung District Agricultural Research and Extension Station, Council of Agriculture, Executive Yuan, Taichung 515, Taiwan.
Lie-Fen ShyurAgricultural Biotechnology Research Center, Academia Sinica, Taipei 115, Taiwan. lfshyur@ccvax.sinica.edu.tw.
Agricultural Biotechnology Research Center, Academia Sinica · TWCouncil of Agriculture · TWNational Taiwan University · TWTaipei Medical University · TW

Funding

Academia Sinica 034007
6 · The paper itself

Abstract

The v-raf murine sarcoma viral homolog B1 (BRAF) inhibitor drug vemurafenib (PLX4032) is used to treat melanoma; however, epidemiological evidence reveals that it could cause cutaneous keratoacanthomas and squamous cell carcinoma in cancer patients with the most prevalent

Indexed as

AnimalsAnticarcinogenic AgentsAnti-Inflammatory AgentsApoptosisCell Cycle CheckpointsDisease Models, AnimalDose-Response Relationship, DrugDrug AntagonismMenthaMiceOils, VolatilePhytochemicalsProtein Kinase InhibitorsProto-Oncogene Proteins B-rafSkin NeoplasmsVemurafenibAnticarcinogenic AgentsAnti-Inflammatory AgentsOils, VolatilePhytochemicalsProtein Kinase InhibitorsProto-Oncogene Proteins B-rafVemurafenibBRAF inhibitorchemopreventionessential oilMentha aquatica var. Kenting Water Minttwo-stage skin carcinogenesis

Identifiers

PMID31242703
PMCPMC6630265
OpenAlexW2954364815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.